- Home
- ELTK vs VNRX Comparison
ELTK vs VNRX Comparison
Compare ELTK & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTK
- VNRX
- Stock Information
- Founded
- ELTK 1970
- VNRX N/A
- Country
- ELTK Israel
- VNRX United States
- Employees
- ELTK N/A
- VNRX N/A
- Industry
- ELTK Electrical Products
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ELTK Technology
- VNRX Health Care
- Exchange
- ELTK Nasdaq
- VNRX Nasdaq
- Market Cap
- ELTK 57.5M
- VNRX 58.6M
- IPO Year
- ELTK 1997
- VNRX N/A
- Fundamental
- Price
- ELTK $8.52
- VNRX $0.57
- Analyst Decision
- ELTK
- VNRX Strong Buy
- Analyst Count
- ELTK 0
- VNRX 4
- Target Price
- ELTK N/A
- VNRX $4.17
- AVG Volume (30 Days)
- ELTK 23.9K
- VNRX 119.1K
- Earning Date
- ELTK 03-11-2025
- VNRX 03-31-2025
- Dividend Yield
- ELTK 2.59%
- VNRX N/A
- EPS Growth
- ELTK N/A
- VNRX N/A
- EPS
- ELTK 0.63
- VNRX N/A
- Revenue
- ELTK $46,527,000.00
- VNRX $1,285,827.00
- Revenue This Year
- ELTK $18.60
- VNRX $71,446.31
- Revenue Next Year
- ELTK $9.04
- VNRX N/A
- P/E Ratio
- ELTK $13.48
- VNRX N/A
- Revenue Growth
- ELTK N/A
- VNRX 97.50
- 52 Week Low
- ELTK $8.05
- VNRX $0.43
- 52 Week High
- ELTK $12.47
- VNRX $1.02
- Technical
- Relative Strength Index (RSI)
- ELTK 31.90
- VNRX 50.47
- Support Level
- ELTK $8.06
- VNRX $0.51
- Resistance Level
- ELTK $8.73
- VNRX $0.57
- Average True Range (ATR)
- ELTK 0.30
- VNRX 0.04
- MACD
- ELTK 0.02
- VNRX 0.00
- Stochastic Oscillator
- ELTK 52.36
- VNRX 60.00
About ELTK Eltek Ltd.
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnects. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.